KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressConvertible DebtCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exact Sciences (EXAS) Other Non-Current Assets (2016 - 2025)

Exact Sciences (EXAS) has disclosed Other Non-Current Assets for 12 consecutive years, with $185.8 million as the latest value for Q4 2025.

  • On a quarterly basis, Other Non-Current Assets rose 9.48% to $185.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was $185.8 million, a 9.48% increase, with the full-year FY2025 number at $185.8 million, up 9.48% from a year prior.
  • Other Non-Current Assets was $185.8 million for Q4 2025 at Exact Sciences, up from $174.9 million in the prior quarter.
  • In the past five years, Other Non-Current Assets ranged from a high of $185.8 million in Q4 2025 to a low of $54.7 million in Q2 2021.
  • A 5-year average of $122.0 million and a median of $110.8 million in 2022 define the central range for Other Non-Current Assets.
  • Peak YoY movement for Other Non-Current Assets: surged 164.37% in 2021, then fell 25.42% in 2025.
  • Exact Sciences' Other Non-Current Assets stood at $74.6 million in 2021, then grew by 21.43% to $90.6 million in 2022, then soared by 95.84% to $177.4 million in 2023, then dropped by 4.32% to $169.7 million in 2024, then rose by 9.48% to $185.8 million in 2025.
  • Per Business Quant, the three most recent readings for EXAS's Other Non-Current Assets are $185.8 million (Q4 2025), $174.9 million (Q3 2025), and $124.9 million (Q2 2025).